Beriplex P/N 1000 1240 Unit

BERIPLEX P/N 1000 1240 Unit is a coagulation factor IX (human) powder for solution, used for managing bleeding disorders. This intravenous medication supports blood clotting and is manufactured by CSL Behring Canada Inc.

BERIPLEX P/N 1000 1240 Unit is primarily used to manage bleeding episodes in individuals with coagulation disorders. It contains coagulation factor IX (human), which helps in blood clotting. This medication is often used for what is coagulation factor IX used for, including controlling bleeding in conditions like hemophilia B.

Common effects of BERIPLEX P/N 1000 1240 Unit may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild allergic reactions. It is important to monitor for any unusual symptoms and consult a healthcare provider if they occur.

BERIPLEX P/N 1000 1240 Unit should be handled with care, ensuring proper storage and preparation. It is crucial to follow the instructions for intravenous administration to avoid complications. Individuals with known allergies to any components should exercise caution.

BERIPLEX P/N 1000 1240 Unit may interact with other medications that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.